PLX:NYSEAMERICAN
Protalix Biotherapeutics Inc
$2.66
arrow_downward
-3.97%(-0.11) 1D
$2.68
arrow_upward
+0.75% (+0.020)bedtimeAfter hours
Closed: Sep 15, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLX...
Open
$2.75
High
$2.75
Low
$2.64
Mkt. cap
214.32M
Avg. vol.
790.01K
Volume
812.74K
P/E ratio
11.76
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
0.02
Shares outstanding
80.57M
No. of employees
226
Open
$2.75
High
$2.75
Low
$2.64
Mkt. cap
214.32M
Avg. vol.
790.01K
Volume
812.74K
P/E ratio
11.76
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
0.02
Shares outstanding
80.57M
No. of employees
226
News stories
From web sources and news partners
Proactive financial news
·
3 hours ago
Protalix Biotherapeutics Inc Share Price - PLX, RNS News, Articles, Quotes, & Charts (NYSEAMERICAN: PLX)
Profile
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
About Protalix Biotherapeutics Inc
CEODror Bashan
Employees226
Founded1993
HeadquartersKarmiel, North District, Israel
SectorBiotechnology
Websiteprotalix.com